Which ear drops are safe to use in a patient with tympanostomy (ventilation) tubes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Ear Drops for Patients with Tympanostomy Tubes

Topical antibiotic ear drops without oral antibiotics are the treatment of choice for acute otorrhea in children with tympanostomy tubes, with fluoroquinolone drops (ofloxacin, ciprofloxacin) being the most effective options despite a small increased risk of perforation. 1

Treatment Recommendations

For Acute Tube Otorrhea (Drainage)

  • Prescribe topical antibiotic ear drops ONLY—do not add oral antibiotics for uncomplicated cases. 1
  • Topical antibiotics provide superior coverage against common pathogens including Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), which are frequently responsible for tube otorrhea. 1
  • This approach avoids systemic antibiotic adverse effects and reduces bacterial resistance. 1

Specific Ear Drop Options

Fluoroquinolone drops (preferred for efficacy):

  • Ofloxacin
  • Ciprofloxacin with hydrocortisone
  • Ciprofloxacin with dexamethasone 1

Alternative option:

  • Neomycin plus hydrocortisone 2

Critical Safety Consideration: Perforation Risk

  • Fluoroquinolone ear drops are associated with an increased risk of tympanic membrane perforation requiring tympanoplasty (adjusted hazard ratio 1.61 compared to neomycin-based drops). 2
  • The risk appears higher with ciprofloxacin-corticosteroid combinations (HR 1.94-2.00) compared to ofloxacin alone (HR 1.49). 2
  • Despite this risk, fluoroquinolones remain the recommended choice due to superior antimicrobial coverage for tube otorrhea pathogens. Clinicians should counsel families about this small but real perforation risk. 2

Ototoxicity Concerns

  • Older aminoglycoside-containing drops (neomycin, polymyxin B) carry theoretical ototoxicity risk when applied to the middle ear through patent tubes. 3
  • Short-term use (2 weeks) of neomycin-polymyxin B-dexamethasone drops has been shown safe in clinical studies with no sensorineural hearing loss detected. 4
  • Animal studies demonstrate that ototoxic drops can reach the inner ear through patent tubes and cause cochlear damage, particularly affecting high-frequency hearing. 3

What NOT to Do

Prophylactic Use

  • Do NOT routinely prescribe antibiotic ear drops immediately after tube placement surgery. 1
  • Prophylactic drops lead to unnecessary antibiotic exposure, cost, local side effects (skin irritation, allergic reactions, fungal overgrowth), and do not provide meaningful benefit. 1

Water Precautions

  • Do NOT routinely recommend earplugs, headbands, or swimming avoidance for children with tubes. 1
  • Routine water precautions unnecessarily restrict child activity and decrease quality of life without proven benefit. 1

Administration Technique

  • Instruct caregivers to "pump" the tragus after instilling drops to facilitate medication entry into the middle ear. 1
  • If obstructing discharge is present in the ear canal, teach caregivers to use tissue spears for gentle home cleaning before drop administration. 1

Exceptions Requiring Oral Antibiotics

Add systemic antibiotics only when:

  • Complicated otorrhea with cellulitis of adjacent skin
  • Concurrent bacterial infection requiring systemic treatment (bacterial sinusitis, streptococcal pharyngitis)
  • Immunocompromised patients 1

Follow-Up Requirements

  • The surgeon must examine the ears within 3 months of tube insertion and educate families about the need for routine periodic follow-up until tubes extrude. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Quinolone Ear Drops After Tympanostomy Tubes and the Risk of Eardrum Perforation: A Retrospective Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Research

Tympanostomy tubes and otic drops.

The Laryngoscope, 1983

Research

Safety of topical ear drops containing ototoxic antibiotics.

The Journal of otolaryngology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.